Abstract. previous studies have demonstrated that a small population of cancer stem cell-like cells exists in retinoblastoma. to provide a model for studying this population, we sought to establish a long-term culture from human retinoblastoma that have cancer stem cell-like properties. Fresh tumor tissue was digested and cultured in serum-free medium. tumor spheres formed and were passaged continuously. stem cell properties were examined through immunostaining, real-time quantitative rt-pCr and chemoresistance assay. tumorigenicity of the tumor sphere-forming cells was confirmed by xenograft experiments. Furthermore, we examined the expression of cell surface markers CD44 and CD133. tumor cells expanded as floating spheres for more than 30 passages. Sphere-forming cells overexpressed stem cell genes Oct-4, Nestin and Pax6. Immunostaining of spheres showed positivity for Nestin, pax6 and also ABCG2. In contrast, differentiated cells derived from these spheres expressed high levels of mature retinal cell markers MAp2, GFAp, recoverin, Opsin B and Nrl, and showed immunoreactivity for NF200, GFAp, recoverin and pKCα. Furthermore, both CD44 and CD133 were highly expressed in sphere-forming cells vs. differentiated cells. sphere-forming cells displayed higher chemoresistance to carboplatin as opposed to differentiated cells. Moreover, intraocular injection of as few as 2x10 3 sphere-forming cells into NOD/sCID mice gave rise to new tumors similar to the original patient tumors. these results revealed that the sphere-forming cells preserved their stem cell properties and tumorigenicity, even after longterm culture. this would be a suitable in vitro model to study cancer stem-like cells in retinoblastoma and to develop chemotherapeutic drugs and strategies.
Introduction
retinoblastoma (rb) is a rare type of eye cancer that accounts for only 4% of pediatric malignancies (1) . Nonetheless, it develops rapidly in the retina, and can be fatal if not treated promptly. Although survival rates in patients with rb have been exceptionally high up to 95% in developed countries, the management of retinoblastoma is still a challenge (2). According to the International Classification of Retinoblastoma, globe salvage is achieved in only 47% of group D cases; most eyes with group e retinoblastoma are managed with enucleation (2). Chemotherapeutic drug resistance is common in retinoblastoma (3), resulting in the increased incidence of unsuccessful treatments. therefore, chemoreduction failure defined as unresponsive or recurrent retinoblastoma (4) plays a very important role in the particularly difficult management of advanced cases. previous studies have shown that p-glycoprotein and multidrug resistance proteins (Mrps) may contribute to drug resistance (5) (6) (7) . However, the mechanism involved in resistance and recurrence is still not clear, and improved targeted therapies are essential for alleviating this devastating malignancy.
In past years, one emerging hypothesis postulates that the development of drug-resistant tumors is sustained by a selfrenewing cell subpopulation termed putative cancer stem cells (CsCs) (8) . Current therapies target rapidly dividing cells that comprise the bulk of the tumor while failing to eradicate the CsCs which subsequently re-initiate the entire malignancy. It is likely that these residual CsCs are able to survive in a dormant state for many years after remission due to their resistant ability (9) (10) (11) . this has considerable implications in the way cancer treatment should be conceived.
CSCs have been identified in hematopoietic malignancies as well as in many solid tumors including brain, breast, colon, pancreas, prostate and ovarian cancers (9, 10, (12) (13) (14) (15) (16) . In retinoblastoma, seigel and colleagues (17) demonstrated that a small subpopulation of cancer stem-like cells existed in mouse retinoblastoma cells and human Y79, WerI-rb27 cell lines, which express human embryonic and neuronal stem cell markers. Another study identified tumorigenic retinal stem-like cells in Maintenance of retinal cancer stem cell-like properties through long-term serum-free culture from human retinoblastoma BO 
Materials and methods
Tissue collection and primary tumor sphere formation. Our study was approved by the Institutional review Boards of eye and eNt Hospital (eeNt), Fudan university in accordance with the Declaration of Helsinki. tumor samples were obtained from a 3-year-old female patient with grade group D retinoblastoma according to the International Classification of retinoblastoma (19) . tumor tissues were collected as previously reported (18, 20) , then washed, minced and digested with 0.25% trypsin. Enzymatically dissociated suspensions were filtered (45-µm cell strainer), washed and resuspended in serum-free DMeM/F12 medium (sFM) supplemented with 20 ng/ml human recombinant epidermal growth factor (eGF; peprotech, Rocky Hill, NJ, USA), 20 ng/ml human basic fibroblast growth factor (bFGF; peprotech), B27 supplement (Invitrogen, Carlsbad, CA, usA) and 20 ng/ml recombinant human leukemia inhibitor factor (LIF; Chemicon-Millipore, Billerica, MA, usA) at a density of 10 5 cells/ml. rBCs were removed by Histopaque-1077 (sigma, st. Louis, MO, usA).
Tumor sphere passage and limiting dilution assay. After primary culture for 11 days, tumor spheres formed and were harvested by sedimentation for 10 min. sphere cells were treated with 0.05% trypsin-eDtA (Gibco-Invitrogen), and digestion was terminated with egg trypsin inhibitor (sigma). Dissociated cells (2x10 5 cells/ml) were transferred to low attachment dishes containing the same medium. Media were changed twice a week, and the same procedure was performed during serial passage. For limiting dilution assay, the analysis was performed as described previously (21, 22) . Briefly, dissociated sphere cells were plated in 96-well microplates in 0.2 ml volumes of sFM. Final cell dilutions ranged from 800 to 1 cell/well, and cultures were fed 0.05 ml of sFM every 3 days until Day 10 after which time the fraction of wells not containing tumor spheres for each cell plating density was calculated and plotted against the cells plated per well. the number of cells required to form at least one sphere was determined based on the regression line. the growth curve of tumor cells was also studied as described previously with some minor modifications (23) .
Differentiation assay. to examine the multipotent differentiation of tumor sphere cells, spheres were plated on poly-D-lysinecoated (0.1 mg/ml, Chemicon) and laminin-coated (20 µg/ml, Invitrogen) glass coverslips under differentiating conditions including DMeM/F12 medium, 10% fetal bovine serum (FBs, Hyclone-thermo Fisher scientific, Waltham, MA, usA) and B27, without growth factors. Culture media were fed every 3 days. Cell morphology was assessed 11 days after plating using immunochemistry.
Immunocytochemical staining. Immunostaining of undifferentiated tumor spheres was performed as previously reported (18, 22) . Briefly, spheres were collected and plated onto poly-D-lysine-coated and laminin-coated glass coverslips in sFM for 8 h. Cells were then fixed with 4% paraformaldehyde and stained with antibodies against Nestin, pax6 and ABCG2 (Abcam, Cambridge, MA, usA). For differentiated tumor cells, immunochemistry was performed against NF200 (sigma), GFAp (Chemicon), recoverin (Abcam) and pKCα (santa Cruz Biotechnology, CA, usA). A list of primary antibodies with their dilutions and suppliers is provided in table I. For immunofluorescence studies, anti-mouse-FITC, anti-rabbit-Cy3 and anti-mouse-Cy3 (Jackson Immunoresearch Laboratories, West Grove, pA, usA) were used as secondary antibodies. Nuclei were counterstained with DApI (Invitrogen). staining was observed by inverted fluorescence microscopy (Nikon).
Real-time quantitative RT-PCR. Gene expression was quantified
by real-time quantitative rt-pCr using sYBr Green Master Mix (toyobo, Japan). total rNA was extracted from sphereforming cells, differentiated cells or parental tumor tissue, and was reverse transcribed into cDNA. All the primer sets for amplification are provided in Table II . Real-time RT-PCR was performed in 384-well plates on a sequence-detection system (ABI prIsM 7900; Applied Biosystems, Inc., Foster City, CA). the relative expression of the sphere-forming and differentiated group was presented as fold change compared to that of the parental tumor tissue, and was normalized to hGAPDH expression in each group. The comparative Ct (∆∆Ct) method was used to obtain quantitative data of relative gene expression, according to the manufacturer's instructions.
Chemotherapy sensitivity assay. Chemoresistance of both sphere cells and differentiated cells to carboplatin was Mouse monoclonal 1:400 pKCα santa Cruz rabbit polyclonal 1:400 Biotechnology assessed using methods previously described with some modifications (9) . Briefly, spheres were trypsinized, dissociated and seeded at 10 4 cells per well into 96-well plates. In parallel, differentiated cells were trypsinized and replated at the same density. Carboplatin at various concentrations was added 48 h after plating. Drug cytotoxicities were determined 48 h after treatment by Cell Counting Kit-8 (CCK-8, Dojindo Molecular technologies, rockville, MD, usA). the same cells (sphere and differentiated cells) without carboplatin treatment were used as control following the kit protocol. All results were based on at least four parallel measurements for each time, and each measurement was repeated in up to three independent experiments.
In vivo xenograft experiments. Xenograft experiments were performed on 4-to 6-week-old female NOD/sCID (non-obese diabetic, severe combined immunodeficient) mice. All mice were maintained in the Animal Facility of shanghai Jiao tong university school of Medicine, and our experimental studies conformed to the ArVO statement for the use of Animals in Ophthalmic and Vision research. to evaluate the tumorigenicity of the tumor sphere-forming cells, dissociated tumor cells were counted and resuspended in pBs with various cell concentrations. under a binocular surgical microscope, a 5-µl cell suspension was transsclerally injected into the vitreous cavity through a 5-µl microsyringe, whereas the contralateral eyeball was injected with 5 µl pBs as control. engrafted mice were inspected biweekly and sacrificed after 10-12 weeks.
Eyeballs were enucleated, fixed in 4% paraformaldehyde and embedded for paraffin or cryostat sections. Hematoxylin and eosin (H&E) staining was performed on paraffin sections, and cryostat sections were used for detection of Nestin, Nse (Neomarker-Thermo Fisher Scientific), GFAP and recoverin. Immunodetection was performed using an Immunopure ABC staining kit (santa Cruz Biotechnology).
Flow cytometry. sphere-forming cells from 7-10 days of different passages were dissociated by 0.05% trypsin and then resuspended in pBs with 1% BsA and 0.1% sodium azide. Aliquots of single cells were evaluated by flow cytometry with a FACs Calibur machine (BD Bioscience, san Jose, CA, usA) using pe-conjugated anti-human CD133 (Miltenyi Biotec, Germany) and ApC-conjugated anti-human CD44 (eBioscience, san Diego, CA, usA) according to the manufacturer's recommendations.
Statistics. Values are presented as the mean ± sD. statistical analyses were performed by the student's t-test. A level of p<0.05 was considered to be statistically significant.
Results

Maintenance of sphere-forming, proliferation and differentiation capacity of original CSCs after long-term culture.
sphere formation is considered an ideal in vitro assay to identify cancer stem cells (24) . A previous study showed that (18) . In our study, long-term primary cultures were established which were able to be expanded as floating spheres for >30 passages. primary tumor specimens were dissociated and incubated in serum-free medium containing growth factors. After primary spheres were observed 11 days later, these floating spheres were enzymatically dissociated as single cells and replated two times every three weeks to generate secondary spheres. Instead of fetal bovine serum, egg trypsin inhibitor was used to neutralize without inducing differentiation of potential self-renewing cells. After 160 days, sustainable tumor spheres were obtained (Fig. 1A) and passaged weekly, indicating that self-renewing cells were maintained in these floating spheres. the population doubling time of the sphere-forming cells was ~60 h as determined from the growth curve of passage 20 spheres (Fig. 2A) . Limiting dilution assay (Fig. 2B ) revealed that at least 179.88 cells were required to generate one tumor sphere. Based on poisson distribution and intersection at the 37% level, the minimal frequency of cancer stem-like cells in the sphere population was estimated to be 0.6%. Immunocytochemical staining of spheres from passage 25 showed positivity for retinal stem cell markers Nestin, pax6 and also ABCG2 which has an important role in maintaining retinal stem cell properties (25) (Fig. 1A) .
to determine whether tumor spheres maintain their differentiation potential during long-term culture, spheres were plated on poly-D-lysine-and laminin-coated dishes under differentiating conditions. During the first 4 h after plating, floating spheres attached to the culture dishes rapidly. the outgrowth of cells and the extension of cell processes were observed. After 5-6 days, the majority of sphere cells migrated out of the sphere edge, growing as flat, neuron-like or fibroblast-like cell shapes. Expression of mature retinal cell markers was examined during the following 3-4 days; immunoreactivity for neurofilament 200 (NF200, neurons), glial fibrillary acidic protein (GFAP, glial cells), recoverin (photoreceptors) and protein kinase Cα (pKCα, bipolar cells) was demonstrated (Fig. 1B) .
Differences in gene expression between sphere-forming cells and differentiated cells derived from the spheres.
We next examined expression of genes specific to embryonic or retinal stem cells and mature retinal cells in both undifferentiated spheres and differentiated cells. rNA extracted from passage 25-27 spheres and differentiated cells derived from those spheres was analyzed by real-time quantitative rt-pCr (Fig. 3) . the expression level in sphere-forming or differentiated cells was relative to that of parental tumor tissue. sphere-forming cells overexpressed stem cell markers for Oct-4, Nestin and Pax6, which are essential for embryonic, neural and retinal development respectively (26) (27) (28) (29) . In contrast, differentiated cells had greatly reduced expression of these genes while they expressed markedly elevated levels of transcripts encoding mature retinal cell markers, such as microtubule-associated protein-2 (MAp2, neurons), GFAp, recoverin (photoreceptors), Opsin B (blue cone photoreceptors) and Nrl (a subtype decision transcription factor for rod photoreceptors). These findings provide evidence that sphere-forming cells maintain the ability to differentiate, and differentiated cells retain a different gene expression signature from sphere-forming cells after longterm culture, which is consistent with their different phenotypes.
Sphere-forming cells display chemoresistance to carboplatin.
to investigate whether the retinal cancer stem-like cells display resistance to conventional chemotherapies, sphereforming cells and differentiated cells were exposed to carboplatin, a basic chemotherapeutic agent for retinoblastoma chemoreduction (1, 30) . Cell viable assays showed that sphereforming cells were dramatically resistant to carboplatin at different concentrations compared to differentiated cells (Fig. 4) . Meanwhile, carboplatin IC 50 values were greater (p<0.01) for sphere cells under stem cell conditions (87.94 µmol/ l) vs. differentiating conditions (25.05 µmol/l). these results indicate that cancer stem-like cells may contribute to the common drug resistance in retinoblastoma.
Maintenance of tumorigenicity of sphere-forming cells after long-term culture.
Another essential criterion for cancer stem cells is their in vivo capacity for self-renewal and recapitulation of the original tumor. to examine whether the sphere-forming cells perpetuate tumorigenicity through long-term culture, various amounts of sphere-forming cells from passage 21 were injected into the vitreous cavity of NOD/sCID mice. After 10-12 weeks of latency, one of two mice with a minimum injection of 2x10 3 cells was found to have formed a visible gross tumor, and the other was observed through a microscope to present tumor formation. Correspondingly, injections of 2x10 4 , 2x10 5 and 2x10 6 sphere-forming cells were also markedly tumorigenic in both of two mice of three groups within 10 weeks (Fig. 5A and B) . the orthotopic xenograft tumors (Fig. 5C and D) presented dense monotonous proliferation with atypical nuclei and scanty cytoplasm, accompanied with eosinophilic necrotic substance, all of which resembled histological features of the original patient tumors (Fig. 5e  and F ). Many cells in the xenografts expressed Nestin, neuron specific enolase (Nse), while fewer cells showed positive staining for recoverin. Consistent with previous reports (18), we did not observe the expression of GFAp (Fig. 5G ) in the xenograft tumors which is present in the immunoreactivity of in vitro tumor cells. As a previous study reported that tumor neural stem-like cells in glioblastomas were multipotent in vitro but monopotent or bipotent in vivo (31) , the difference between xenograft tumor cells and in vitro tumor cells might indicate that cancer stem-like cells are affected by the cell microenviroment during the course of in vivo assay (24) . taken together, the in vivo tumorigenicity was stably maintained even after a long period of cultivation.
Overexpression of cell surface markers CD44 and CD133 in sphere-forming cells during long-term culture. Based on both our biological and functional characterization of the long-term cultures of retinal tumorigenic cells with stem cell properties, we further examined the expression of cell surface proteins CD44 and CD133 in our culture cells, each of which have been used to identify cancer stem cells from different types of tumors (9, 10, 14, 15, 22, 32, 33) . strikingly, both CD44 and CD133 have a similar expression pattern with stem cell markers. Compared with cells under stem cell conditions, gene expression of CD44 and CD133 was significantly reduced under differentiating conditions (Fig. 6) . Furthermore, flow cytometric analysis was performed to evaluate the percentage of these two markers in various passages. With sphere-forming cells propagated from passage 1 to passage 25, the percentage of CD44 + CD133 -population decreased while that of the CD44 + CD133 + population increased under stem cell conditions. In contrast, CD44 + CD133 + cells were present in a much lower percentage when cells were transferred to differentiating conditions ( Fig. 7; table III) . these results indicate that CD44 combined with CD133 could be a potential candidate cell surface marker for retinal cancer stem-like cells.
Discussion
there is increasing evidence for the presence of cancer stem cells in malignant tumors. this subpopulation may play a Figure 5 . sphere-forming cells from passage 21 generated tumors in NOD/sCID mice after orthotopic transplantation. Injection of at least 2x10 3 dissociated sphere-forming cells generated tumors within 10-12 weeks (A). representative mouse eyeball with a xenograft tumor exhibited corneal necrosis and was abnormally larger than normal control eye with injection of pBs (B). Hematoxylin and eosin (H&e) staining showed that the transplanted tumor (C and D) exhibited typical histological features of human Rb (E and F). Magnification, x40 (C and E); x400 (D and F). At a lower magnification, the invasive original tumor (t) damaged the retina, spread to the vitreous cavity and reached the posterior of the lens (l). similarly, the xenograft tumor bulk (t) was visible behind the lens (l) and infiltrated the retina (r), choloid and sclera (s). At a higher magnification, the xenograft tumors (D) had atypical small rounded nuclei with scanty cytoplasm, and eosinophilic necrotic substance, all of which resembled the histological features of the original patient tumors (F). Immunochemical staining indicated that the xenograft tumor expressed nestin, neuron specific enolase (NSE) and recoverin, but not GFAP (G). pivotal role in tumor initiation, growth, chemoresistance and recurrence (34, 35) . to establish a more detailed understanding, functional assays of this subpopulation have been evaluated, and consequently long-term cultures of cancer stem-like cells have been established recently in several types of malignancies (9, 32, (36) (37) (38) .
In the present study, serum-free culture conditions were applied as previously described (18, 22) for the culturing of retinal cancer stem-like cells obtained from human rb lesions. serum-free medium allows for the maintenance of an undifferentiated stem cell state, and addition of eGF and bFGF induces the proliferation of multipotent, self-renewing neural stem cells (22) . similar serum-free medium has also been used for long-term culture of human retinal progenitor cells; the majority of cells continue to express progenitor markers as well as the ability to express markers of neuronal and glial lineage in vitro. (Yang J, et al, IOVs 51: ArVO e-abs. 2649, 2010). Fortunately, we established long-term cultures of retinal cancer stem-like cells as non-adherent tumor spheres, which can be derived to differentiate as adherent neuron-like or fibroblast-like cells. The ability of cells to generate spheres after serial passages demonstrates their self-renewal potential. In addition, immunocytochemical staining of stem cell markers and the limiting dilution assay both confirmed this longlasting capacity. For the multipotent differentiation criterion for distinguishing stem cells, sphere-forming cells were transferred to differentiating conditions and produced a similar phenotype with rb tumor containing neurons, glial cells and photoreceptors. to confirm that the sphere-forming cells possess the capacity to produce the heterogeneous lineages of tumor cells that comprise the tumor, at least 2x10 3 cells were injected into the vitreous cavity of mice, which resulted in grafted tumors that were histologically identical to the original rb tumors. Moreover, previous reports demonstrated that cancer stem cells are responsible for the natural resistance to chemotherapeutic drugs (9, 11, 39) . to the best of our knowledge, our study is the first to report that sphere-forming cells in retinoblastoma are markedly chemoresistant to carboplatin as opposed to differentiated cells. According to these findings, established long-term cultures can be used as an in vitro model with which to study cancer stem-like cell properties in human retinoblastoma. these cultured cells can be frozen and thawed and still retain the same cancer stem cell properties including capacities of tumor sphere-forming, differentiation and tumorigenicity. Compared to the retinoblastoma cell lines available to date, these cells have a unique characteristic of growing in non-adherent spheres. the doubling time is approximately 60 h, which is longer than Y79 and sNuOt-rb1 cells (23, 40) . Figure 7 . Flow cytometric analysis of CD44 and the CD133 in sphere-forming cells from different passages (p1, p6, p11, p20, p22 and p25) as well as differentiated cells (Diff.). As shown by dot plots, the CD44 + CD133 + population (Q4 quadrant) was increased in the sphere-forming cells, whereas they were greatly reduced when transferred to differentiating conditions. they also produced a tumor with as few as 2x10 3 cells, which is much lower than previously reported. to provide further evidence, karyological examination will be performed in future studies.
As mentioned above, another currently accepted characterization of cancer stem cells is isolation using distinct cell surface antigens. to identify any alterations in cells under stem cell and differentiating conditions, real-time quantitative rt-pCr was used to analyze the gene expression patterns. It is notable that sphere-forming cells overexpressed stem cell genes such as Oct-4, Nestin and Pax6, while differentiated cells showed lower expression of these genes but greater expression of differentiated state genes including MAp2, GFAp, recoverin, Nrl and Opsin B. Moreover, it is interesting that CD44 and CD133 showed a similar expression pattern to stem cell genes. CD44 is a receptor for hyaluronic acid and has been described as a breast, ovarian, gastric, prostate and pancreatic cancer stem cell marker (9, 10, 15, 32, 33) . the CD133 antigen is a penta-span membrane glycoprotein, which has been proposed as both a neural stem cell marker and a CsC marker in brain, colon and other solid tumors (14, 22) . Conversely, some studies imply that CD133 appears to be a component in photoreceptor maintenance and/or function (17) . In retinoblastoma, Balla et al studied the phenotypic characterization for the presence of putative cancer stem-like cell markers using flow cytometric analysis of freshly isolated tumor cells. the authors revealed that the FsC lo /ssC lo subpopulations, which appeared to be more primitive, were positive for CD44 but negative for CD133, CXCr4 and CD90 (41) . In our study, CD44 combined with CD133 indicated the existence of putative cancer stem-like cells in Rb, since there was a significant difference in expression in sphere-forming cells vs. differentiated cells. to verify this possibility, long-term cultures were used as a tool to detect the percentage of CD44-and CD133-positive cells in various passages. As expected, the CD44 + CD133 + population increased in the sphere-forming cells, which may have been enriched and perpetuated in the serum-free medium over a prolonged culture; however, this population was greatly reduced when transferred to differentiating conditions. therefore, CD44 and CD133 could be potential candidate cell surface markers for identifying retinal cancer stem-like cells. However, whether CD44 + CD133 + cells are actually enriched vs. any other cell surface marker combination needs to be further assessed through in vivo experiments isolating and identifying the tumorigenicity of this small subset of tumor cells.
to conclude, long-term cultures of retinal cancer stem-like cells represent a suitable in vitro model with which to study cancer stem-like cells in retinoblastoma and to develop more sensitive chemotherapeutic drugs and therapeutic strategies aimed at eradicating this tumorigenic subpopulation within retinoblastoma.
